Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788767 | SCV000928003 | pathogenic | not provided | 2018-10-18 | criteria provided, single submitter | clinical testing | |
Cavalleri Lab, |
RCV001095562 | SCV001251193 | pathogenic | Polycystic kidney disease, adult type | 2020-02-05 | criteria provided, single submitter | research | PVS1, PM2, PP4, PP5 |
Gene |
RCV000788767 | SCV002578801 | pathogenic | not provided | 2022-04-20 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 17582161, 30333007, 31740684, 33454723) |
Fulgent Genetics, |
RCV001095562 | SCV002810657 | pathogenic | Polycystic kidney disease, adult type | 2022-02-10 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV001095562 | SCV005184181 | pathogenic | Polycystic kidney disease, adult type | 2024-07-19 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PS4_Supporting+PP4 |
Department of Pathology and Laboratory Medicine, |
RCV000501909 | SCV000592789 | pathogenic | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1 p.Gln2067X variant was identified in 1 of 404 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD (Rossetti 2007).The variant was identified in ADPKD Mutation Database (classification definitely pathogenic) and not identified in dbSNP, Clinvitae, ClinVar, GeneInsight COGR, PKD1-LOVD, and PKD1-LOVD 3.0; 1000 Genomes Project, NHLBI GO Exome Sequencing Project (ESP) or the Exome Aggregation Consortium (ExAC) database (Jan 13, 2015). The p.Gln2067X variant leads to a premature stop codon at position 2067, which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the PKD1 gene are an established mechanism of disease in autosomal dominant polycystic kidney disease and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic. |